tiprankstipranks
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Income Statement

Compare
156 Followers

Xilio Therapeutics Income Statement

Last quarter (Q3 2024), Xilio Therapeutics's total revenue was $2.26M, an increase of Infinity% from the same quarter last year. In Q3, Xilio Therapeutics's net income was $-14.02M. See Xilio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.90M$ -1.85M$ -1.50M$ -1.06M$ -240.00K
Operating Expenses
$ 79.13M$ 89.15M$ 75.04M$ 54.56M$ 19.03M
Depreciation and Amortization
$ 1.90M$ 1.85M$ 1.50M$ 1.06M$ 240.00K
EBITDA
$ -73.80M$ -85.58M$ -73.70M$ -53.50M$ -17.07M
Operating Income
$ -79.13M$ -89.15M$ -75.04M$ -54.56M$ -19.03M
Other Income/Expenses
$ 2.73M$ 927.00K$ -756.00K$ -656.00K$ 1.72M
Pretax Income
$ -76.40M$ -88.22M$ -75.80M$ -55.22M$ -17.31M
Net Income
$ -76.40M$ -87.30M$ -74.30M$ -55.22M$ -17.31M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.78$ -3.19$ -2.72$ -2.01$ 0.00
Diluted EPS
$ -2.78$ -3.19$ -2.72$ -2.01$ 0.00
Weighted Average Shares Outstanding
27.50M 27.39M 27.36M 27.47M 27.47B
Weighted Average Shares Outstanding (Diluted)
27.50M 27.39M 27.36M 27.47M 27.47B
Currency in USD

Xilio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis